A Fibrin Specific Monoclonal Antibody which Interferes with the Fibrinolytic Effect of Tissue Plasminogen Activator

Summary

Monoclonal antibodies to human fibrin have been prepared from stable hybridomas, obtained by fusion of a mouse myeloma cell line (NS-1) and spleen cells of Balb/c mice immunized with a suspension of human fibrin. One cell line, DG1, producing a monoclonal antibody of the IgG₁ κ subclass, reacted specifically with human fibrin (K_D = 1.2 nM). Western blotting analysis indicates that DG1 crossreacts with the fibrin fragment D-dimer. Using both a chromogenic and an ¹²⁵I-fibrin release assay it was illustrated that in the presence of the fibrin specific antibody the t-PA mediated generation of plasmin was significantly inhibited.

An animal model system, developed to monitor thrombosis and induced reactive fibrinolysis, was used to investigate the interference of plasminogen activation, by the antibody, in vivo.

This fibrin specific antibody prolonged the onset of reactive fibrinolysis in a dose dependent manner.

Keywords

Fibrin specific antibody - Tissue plasminogen activator

• References

• 1 Blomback T, Hessel B, Hogg D, Therildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 1978; 275: 501-504
• 2 Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrin stabilising factor (factor XIIIa). J Lab Clin Med 1975; 86: 100-111
• 3 Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53: 195-229
• 4 Joist JH. Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Clin Lab Med 1984; 4 (02) 363-381
• 5 Gaffney PJ. Fibrin fragmentation by plasmin: Molecular considerations and their relevance. In: Fibrinogen, Recent Biochemical andMedical Aspects. Henschen A, Graeff H, Lottspeich F. (eds) Walter de Gruyter; Berlin: 1982: 307-327
• 6 Bick RL. The clinical significance of fibrinogen degradation products. Semin Thromb Haemostas 1982; 8: 302-330
• 7 Allington MJ. Detection of fibrin(ogen) degradation products by a latex clumping method. Scand J Haematol 1971; 13: 115
• 8 Merskey C, Kleine GI, Johnson AJ. Quantitative estimation of split products of fibrinogen in human serum relative to diagnosis and treatment. Blood 1966; 28: 1-18
• 9 Gordon YB, Martin MJ, Landon J, Chard T. Development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol 1974; 29: 109-119
• 10 Nossel HL, Butler VP, Wilner GD, Canfield RE, Harfenist EJ. Specificity of antisera to human fibrinopeptide A used in clinical fibrinopeptide A assays. Thromb Haemostas 1976; 35: 101-109
• 11 Plow EF, Edgington TS. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proc Natl Acad Sci USA 1973; 70: 1169-1173
• 12 Budzynski AZ, Marder VJ, Parker ME, Shames P, Brizuela BS, Olexa SA. Antigenic markers on fragment DD: A unique plasmic derivative of human crosslinked fibrin. Blood 1979; 54: 794-804
• 13 Bosnajakovic VB, Jankovic BD, Horvat J, Cvoric J. Radiolabelled anti-human fibrin antibody: A new thrombus detecting agent. Lancet 1979; 8009: 452-454
• 14 Plow EF, Edgington TS. Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes. Semin Thromb Haemostas 1982; 8 (01) 36-56
• 15 Koehler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497
• 16 Hui KY, Haber E, Matsueda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 1983; 22: 1129-1132
• 17 Scheefers-Borchel U, Müller-Berghaus G, Fughe P, Eberle R, Heimburger N. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. Proc Natl Acad Sci USA 1985; 82: 7091-7095
• 18 Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN. Measurement of crosslinked fibrin degradation products. An immunoassay using monoclonal antibodies Thromb Haemostas 1983; 50: 591-594
• 19 Kudryk B, Rohoza. Ahadi M, Chin J, Wiebe ME. Specificity of a monoclonal antibody for the NH₂-terminal region of fibrin. Mol Immunol 1984; 21: 89-94
• 20 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 21 Brockway WJ, Castellino FJ. Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Arch Biochem Biophys 1972; 151: 194-199
• 22 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
• 23 Varadi A, Patthy L. Location of plasminogen binding sites in human fibrin(ogen). Biochemistry 1983; 22: 2440-2446
• 24 Markwell MA K. A new solid-state reagent to iodinate proteins. Anal Biochem 1982; 125: 427-432
• 25 Drapier JC, Tenu JO, Lemaire G, Petit JF. Regulation of plasminogen activator secretion in mouse peritoneal macrophages. Biochemie 1979; 61: 463-471
• 26 Unkeless JC, Tobia A, Ossowski L, Quigly JP, Rifkin DB, Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. J Exp Med 1973; 137: 85-111
• 27 Oi VT, Herzenberg LA. Immunoglobulin producing hybrid cell lines. In: Selected Methods in Cellular Immunology. Mishell BB, Shiigi SM. (eds) San Francisco, CA: 1980: 351-372
• 28 Gemski MJ, Doctor BP, Gentry MK, Pluskal MG, Strickler MP. Single step purification of monoclonal antibody from murine ascites and tissue culture fluids by anion exchange high performance liquid chromatography. Biotechniques 1985; 3 (05) 378-384
• 29 Law H, Lingwood CA. Use of fluorescent standards in protein transfer and immunoblotting. Accurate estimation of the molecular weight of immunoreaetive species Anal Biochem 1985; 149: 404-408
• 30 Frankel ME, Gerhard W. The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus Mol Immunol 1979; 16: 101-106
• 31 Ploplis VA, Cummings HS, Castellino FJ. Monoclonal antibodies to discrete regions of human Glu-Plasminogen. Biochemistry 1982; 21: 5891-5897
• 32 Soria J, Soria C, Mirshahi M, Boucheix C, Aurengo A, Perrot J, Bemadou A, Samama M, Rosenfeld C. Conformational change in fibrinogen induced by adsorption to a surface. J Colloid Interface Sci 1985; 107 (01) 204-208